← Eichor
Study identifier: NCT05635175 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effectiveness of a Hip Abductor Training in Women With Stress Urinary Incontinence

Condition: Women With Stress Urinary Incontinence  ·  Sponsor: University Hospital, Rouen

PhaseNA
Planned participants78
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Urinary incontinence (UI) is estimated to affect 25% à 45 % women all over the world. UI is associated with a poor Quality of life, with a strong level of certainty. Stress urinary incontinence (SUI) is the second more prevalent type of UI . First-line treatment for SUI is conservative, non-drug and non-surgical treatment. Among these techniques, physiotherapist-supervised pelvic floor muscle (PFM) training (PFMT) as a first-line treatment; however, only half of women with SUI are cured with PFMT. Brain imaging shows that PFMs (involved in continence mechanisms) and gluteal muscles can activate the same cortical region. This synergy is found if the gluteal muscles are voluntarily activated, but not if the PFMs are volontary activated alone . In women, hip abductor physiotherapy is a common practice which has already been the subject of a very extensive literature and has largely shown its effectiveness in the quality of lumbo-pelvic control, balance, quality of life and risk of fall prevention. This rehabilitation is based on exercises that induce solicitation of the hip abductors by synergistic reflex activation during a range of well-known exercises. Recent work has shown the effect of hip abductors on the activation of the PFMs . Until today, there is no literature evaluating the effectiveness of a hip abductors training program without associated voluntary contraction of the PFMs (PPM) on UI. The hypothesis of this work will be to demonstrate that a complementary trainin…

This description comes directly from the study's public registry record.

Talk to the study team

Benoit STEENSTRUP, physiotherapist  ·  +33 2 32 88 89 90  ·  benoit.stennstrup@chu-rouen.fr

Déborah LEBEDIEFF  ·  +33 2 32 88 89 90  ·  deborah.lebedieff@chu-rouen.fr

Always discuss trial participation with your own doctor first.

Locations (3)

Pôle santé de la Grace DieuCaen, FranceRecruiting
Chu RouenRouen, FranceRecruiting
Médipôle du RouvraySaint-Étienne-du-Rouvray, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05635175